Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.
Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.
复制标题
山槐种子凝集素(MASL)对口腔鳞状细胞癌(OSCC)基因表达和转录信号通路的影响。
DOI:
10.1007/s00432-020-03456-8
复制
发表时间:
2021-03
影响因子:
3.6
通讯作者:
Goldberg GS
中科院分区:
文献类型:
--
作者:
Hamilton KL;Sheehan SA;Retzbach EP;Timmerman CA;Gianneschi GB;Tempera PJ;Balachandran P;Goldberg GS
Oral cancer causes over 120,000 deaths annually and affects the quality of life for survivors. Over 90% of oral cancers are derived from oral squamous cell carcinoma cells (OSCCs) which are generally resistant to standard cytotoxic chemotherapy agents. OSCC cells often exhibit increased TGFβ and PDPN receptor activity compared to nontransformed oral epithelial cells. Maackia amurensis seed lectin (MASL) can target the PDPN receptor and has been identified as a novel agent that can be used to treat oral cancer. However, mechanisms by which MASL inhibits OSCC progression are not yet clearly defined. Here, we performed cell migration and cytotoxicity assays to assess the effects of MASL on OSCC motility and viability at physiologically relevant concentrations. We then performed comprehensive transcriptome analysis combined with transcription factor reporter assays to investigate the how MASL affects OSCC gene expression at these concentration. Key data were then confirmed by western blotting to evaluate the effects of MASL on gene expression and kinase signaling activity at the protein level. MASL significantly affected the expression of about 27% of approximately 15 thousand genes found to be expressed by HSC-2 cells used to model OSCC cells in this study. These genes affected by MASL include members of the TGFβ-SMAD, JAK-STAT, and Wnt-βCTN signaling pathways. In particular, MASL decreased expression of PDPN, SOX2, and SMAD5 at the RNA and protein levels. MASL also inhibited SMAD and MAPK activity and exhibited potential for combination therapy with doxorubicin and 5-fluorouracil. Taken together, results from this study indicate that MASL decreases activity of JAK-STAT, TGFβ-SMAD, and Wnt-βCTN signaling pathways to inhibit OSCC growth and motility. These data suggest that further studies should be undertaken to determine how MASL may also be used alone and in combination with other agents to treat oral cancer.
登录
查看更多内容
影响因子:
4.6
作者:
Chung JH;Jung HR;Jung AR;Lee YC;Kong M;Lee JS;Eun YG
通讯作者:
Eun YG
影响因子:
4.6
作者:
Bresson, Laura;Faraldo, Marisa M.;Deugnier, Marie-Ange
通讯作者:
Deugnier, Marie-Ange
影响因子:
3.8
作者:
D'Andrea, Alan D.
通讯作者:
D'Andrea, Alan D.
影响因子:
64.5
作者:
Laherty, CD;Yang, WM;Eisenman, RN
通讯作者:
Eisenman, RN
影响因子:
4.8
作者:
Chou, Ming-Yung;Hu, Fang-Wei;Yu, Cheng-Chia
通讯作者:
Yu, Cheng-Chia